These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 15753763)
1. Inotropic options for postresuscitation myocardial dysfunction. Gazmuri RJ; Kolarova JD; Ayoub IM Crit Care Med; 2005 Mar; 33(3):668-70. PubMed ID: 15753763 [No Abstract] [Full Text] [Related]
2. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction. Huang L; Weil MH; Tang W; Sun S; Wang J Crit Care Med; 2005 Mar; 33(3):487-91. PubMed ID: 15753736 [TBL] [Abstract][Full Text] [Related]
3. Levosimendan improves postresuscitation outcomes in a rat model of CPR. Huang L; Weil MH; Sun S; Cammarata G; Cao L; Tang W J Lab Clin Med; 2005 Nov; 146(5):256-61. PubMed ID: 16242524 [TBL] [Abstract][Full Text] [Related]
5. Levosimendan and gut mucosal blood flow--not all inotropes are created equal. Coopersmith CM Crit Care Med; 2005 Jan; 33(1):246-7. PubMed ID: 15644686 [No Abstract] [Full Text] [Related]
6. Levosimendan in cardiac surgery: a unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application? Pagel PS Anesth Analg; 2007 Apr; 104(4):759-61. PubMed ID: 17377077 [No Abstract] [Full Text] [Related]
7. Levosimendan improves postresuscitation myocardial dysfunction after beta-adrenergic blockade. Wang J; Weil MH; Tang W; Sun S; Huang L J Lab Clin Med; 2005 Sep; 146(3):179-83. PubMed ID: 16131457 [TBL] [Abstract][Full Text] [Related]
8. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure? Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618 [TBL] [Abstract][Full Text] [Related]
9. Levosimendan for heart-operated patients: what is the state of the art? Tagarakis GI; Tsilimingas NB Recent Pat Cardiovasc Drug Discov; 2009 Jan; 4(1):22-4. PubMed ID: 19149702 [TBL] [Abstract][Full Text] [Related]
10. Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output. Elahi MM; Lam J; Asopa S; Matata BM J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1154-62. PubMed ID: 21376634 [No Abstract] [Full Text] [Related]
12. Resuscitation from adrenaline resistant electro-mechanical dissociation facilitated by levosimendan in a young man with idiopathic dilated cardiomyopathy. Tsagalou EP; Nanas JN Resuscitation; 2006 Jan; 68(1):147-9. PubMed ID: 16325323 [TBL] [Abstract][Full Text] [Related]
13. Levosimendan: right for the right ventricle? Lambermont B; Ghuysen A; Harstein G; D'Orio V Crit Care Med; 2007 Aug; 35(8):1995-6. PubMed ID: 17667254 [No Abstract] [Full Text] [Related]
14. Treatment of post resuscitation myocardial dysfunction: aortic counterpulsation versus dobutamine. Tennyson H; Kern KB; Hilwig RW; Berg RA; Ewy GA Resuscitation; 2002 Jul; 54(1):69-75. PubMed ID: 12104111 [TBL] [Abstract][Full Text] [Related]
15. Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application. Editorial to: "Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz et al.". Damman K; Voors AA Cardiovasc Drugs Ther; 2007 Dec; 21(6):403-4. PubMed ID: 18030611 [No Abstract] [Full Text] [Related]
16. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan. García González MJ; Domínguez Rodríguez A Am J Cardiovasc Drugs; 2006; 6(2):69-75. PubMed ID: 16555860 [TBL] [Abstract][Full Text] [Related]
17. Oxygen-wasting effect of inotropy: is there a need for a new evaluation? An experimental large-animal study using dobutamine and levosimendan. Müller S; How OJ; Jakobsen Ø; Hermansen SE; Røsner A; Stenberg TA; Myrmel T Circ Heart Fail; 2010 Mar; 3(2):277-85. PubMed ID: 20018954 [TBL] [Abstract][Full Text] [Related]